Vimarsana
Biggest News Aggregation in the World

Gu Cancers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gu Cancers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gu Cancers Today - Breaking & Trending Today

Individualized Approach Best Informs Choice of Frontline Immunotherapy or Targeted Therapy Combinations Across RCC Histologies - Vimarsana News

Individualized Approach Best Informs Choice of Frontline Immunotherapy or Targeted Therapy Combinations Across RCC Histologies

Benjamin Garmezy, MD, discusses challenges associated with navigating the current frontline armamentarium in both clear cell and variant RCC, the impact of frontline IO doublets and IO/TKI regimens on patient outcomes, and the importance of ongoing combination studies for patients with variant RCC.

Dr Tsao on the Investigation of Cabozantinib With Nivolumab and Ipilimumab in RCC - Vimarsana News

Dr Tsao on the Investigation of Cabozantinib With Nivolumab and Ipilimumab in RCC

Che-Kai Tsao, MD, discusses the investigation of cabozantinib in combination with nivolumab and ipilimumab in patients with renal cell carcinoma.

Dr Mike Lattanzi: Precision Oncology Options and Increasing Rates of Prostate Cancer - Vimarsana News

Dr Mike Lattanzi: Precision Oncology Options and Increasing Rates of Prostate Cancer

Mike Lattanzi, MD, genitourinary medical oncologist, Texas Oncology, discusses the importance of keeping pace with precision oncology options as rates for prostate cancer increase.

Source: ajmc.com